Tag: Reverse Payment Settlements
Consumer Welfare In Competition And Intellectual Property Law
Herbert Hovenkamp, Dec 20, 2013
Whether antitrust policy should pursue a goal of “general welfare” or “consumer welfare” has been debated for decades. The academic...
Evaluating the Size of Reverse Payments In Light of the Supreme...
James Langenfeld, Dec 30, 2013
Patent settlement agreements that involve payments from brand-name drug manufacturers to generic drug manufacturers (so called "reverse payments" or "pay...
When Does Interpretation Become Rewriting? The FTC Runs With the Actavis...
Kent Bernard, Sep 30, 2013
A Hatch-Waxman settlement case finally reached the Supreme Court, and when it did the Court in FTC v. Actavis rejected both...
European Commission Enforcement in the Pharmaceutical Sector: Less Than Expected? The...
Sean-Paul Brankin, Jul 27, 2012
On July 6, 2011, the European Commission closed the case file in itsBoehringer/Almirall investigation. It did so without a formal...
Cervantes Sequel: The FTC’s Quest to End Pay-for-Delay Pharma Settlements
Anne Layne-Farrar, Jun 27, 2012
We are drawing close to the thirtieth anniversary of the Drug Price Competition and Patent Term Restoration Act, better known...
Pharmaceutical Patent Settlements – A Presumption in Reverse
This article is part of a Chronicle. See more from this Chronicle
Patrick Harrison, Kristina Nordlander, Aug 13, 2009
On July 8, 2009, the European Commission's...
